Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xiaowan Chen, Junhua Zhao, Ailin Li, Peng Gao, Jingxu Sun, Yongxi Song, Jingjing Liu, Ping Chen & Zhenning Wang. (2016) Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis. OncoTargets and Therapy 9, pages 3205-3212.
Read now
Read now
Valentina Zanfagnin, Annamaria Ferrero, Nicoletta Biglia, Giovanni Aletti, Sarah E. Gill, Peter B. Makdisi, Francesco Multinu & Andrea Mariani. (2016) The role of surgery in recurrent endometrial cancer. Expert Review of Anticancer Therapy 16:7, pages 741-750.
Read now
Read now
Amanda Nickles Fader, David Boruta, Alexander B Olawaiye & Paola A Gehrig. (2009) Updates on uterine papillary serous carcinoma. Expert Review of Obstetrics & Gynecology 4:6, pages 647-657.
Read now
Read now
Nicanor I Barrena Medel, Sharmilee Bansal, David Scott Miller, Jason D Wright & Thomas J Herzog. (2009) Pharmacotherapy of endometrial cancer. Expert Opinion on Pharmacotherapy 10:12, pages 1939-1951.
Read now
Read now
Articles from other publishers (31)
Arti Tyagi, Mohammad A. Kamal & Nitesh Kumar Poddar. (2020) Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease. Frontiers in Neuroscience 14.
Crossref
Crossref
Kristýna Němejcová, Jana Rosmusová, Michaela Bártů, Miroslav Důra, Ivana Tichá & Pavel Dundr. (2016) Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases. International Journal of Surgical Pathology 25:5, pages 389-396.
Crossref
Crossref
Liyan Chen, Tiefeng Jin, Kun Zhu, Yingshi Piao, Taihao Quan, Chunji Quan & Zhenhua Lin. (2017) PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer. Oncotarget 8:7, pages 11937-11949.
Crossref
Crossref
Hiroshi Shimada, Seiro Satohisa, Takayuki Kohno, Syunta Takahashi, Tsubasa Hatakeyama, Takumi Konno, Mitsuhiro Tsujiwaki, Tsuyoshi Saito & Takashi Kojima. (2016) The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells. Oncotarget 7:19, pages 27735-27752.
Crossref
Crossref
Mohamed Mokhtar Desouki & Oluwole Fadare. 2015. Molecular Oncology Testing for Solid Tumors. Molecular Oncology Testing for Solid Tumors
507
535
.
Patricia M. Baker & Esther Oliva. 2018. Uterine Cancer. Uterine Cancer
107
146
.
Takiko Daikoku, Jumpei Terakawa, Md M. Hossain, Mikihiro Yoshie, Monica Cappelletti, Peiying Yang, Lora H. Ellenson & Sudhansu K. Dey. (2014) Mammalian Target of Rapamycin Complex 1 and Cyclooxygenase 2 Pathways Cooperatively Exacerbate Endometrial Cancer. The American Journal of Pathology 184:9, pages 2390-2402.
Crossref
Crossref
Georgios Androutsopoulos, Georgios Michail, Georgios Adonakis & Georgios Decavalas. (2014) ErbB Receptors and ErbB Targeted Therapies in Endometrial Cancer. Journal of Cancer Therapy 05:06, pages 483-492.
Crossref
Crossref
Li-rong Meng. (2014) Effect of mTOR Inhibitors in Nude Mice with Endometrial Carcinoma and Variable PTEN Expression Status. Medical Science Monitor Basic Research 20, pages 146-152.
Crossref
Crossref
Dariusz Samulak, Patrycja Grosman-Dziewiszek, Magdalena M. Michalska, Ewa Mojs, Katarzyna Samulak, Hanna Romanowicz & Beata Smolarz. (2013) Evaluation of Expression of the PTEN Gene, Oestrogen and Progesterone Receptors as Diagnostic and Predictive Factors in Endometrial Cancer. Pathology & Oncology Research 20:1, pages 191-196.
Crossref
Crossref
Masayuki Someya, Takashi Kojima, Marie Ogawa, Takafumi Ninomiya, Kazuaki Nomura, Akira Takasawa, Masaki Murata, Satoshi Tanaka, Tsuyoshi Saito & Norimasa Sawada. (2013) Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. Cell and Tissue Research 354:2, pages 481-494.
Crossref
Crossref
Kavita S. Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Noor Azmi Mat Adenan & Ivy Chung. (2013) Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLoS ONE 8:7, pages e68923.
Crossref
Crossref
S. Poujol, F. Bressolle, I. Solassol & F. Pinguet. (2012) Stability of ready-to-use temsirolimus infusion solution (100mg/L) in polypropylene containers under different storage conditions. Annales Pharmaceutiques Françaises 70:3, pages 155-162.
Crossref
Crossref
Tian Li, Yuebo Yang, Xiaomao Li, Chengfang Xu & Lirong Meng. (2011) EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells. Molecular and Cellular Biochemistry 361:1-2, pages 19-29.
Crossref
Crossref
Sharmilee Bansal Korets, Sarah Czok, Stephanie V. Blank, John P. Curtin & Robert J. Schneider. (2011) Targeting the mTOR/4E-BP Pathway in Endometrial Cancer. Clinical Cancer Research 17:24, pages 7518-7528.
Crossref
Crossref
Angiolo Gadducci, Stefania Cosio & Andrea Riccardo Genazzani. (2011) Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer. Critical Reviews in Oncology/Hematology 80:2, pages 181-192.
Crossref
Crossref
Xiangbing Meng, Pavla Brachova, Shujie Yang, Zhi Xiong, Yuping Zhang, Kristina W. Thiel & Kimberly K. Leslie. (2011) Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment. PLoS ONE 6:6, pages e20920.
Crossref
Crossref
Cheryl Clark, Oleksandr Ekshyyan & Cherie-Ann O. Nathan. 2011. Signaling Pathways in Squamous Cancer. Signaling Pathways in Squamous Cancer
383
405
.
Diana Lim & Esther Oliva. (2010) Nonendometrioid endometrial carcinomas. Seminars in Diagnostic Pathology 27:4, pages 241-260.
Crossref
Crossref
Patricia E. Ellis & Sadaf Ghaem-Maghami. (2010) Molecular Characteristics and Risk Factors in Endometrial Cancer. International Journal of Gynecological Cancer 20:7, pages 1207-1216.
Crossref
Crossref
Curtis Balch, Daniela E Matei, Tim H-M Huang & Kenneth P Nephew. (2010) Role of epigenomics in ovarian and endometrial cancers. Epigenomics 2:3, pages 419-447.
Crossref
Crossref
John Moroney, Jennifer Wheler, David Hong, Aung Naing, Gerald Falchook, Diane Bodurka, Robert Coleman, Karen Lu, Lianchun Xiao & Razelle Kurzrock. (2010) Phase I clinical trials in 85 patients with gynecologic cancer: The M. D. Anderson Cancer Center experience. Gynecologic Oncology 117:3, pages 467-472.
Crossref
Crossref
Amanda Nickles Fader, David Boruta, Alexander B Olawaiye & Paola A Gehrig. (2010) Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Current Opinion in Obstetrics & Gynecology 22:1, pages 21-29.
Crossref
Crossref
Kieran Brennan, Gozie Offiah, Elaine A. McSherry & Ann M. Hopkins. (2010) Tight Junctions: A Barrier to the Initiation and Progression of Breast Cancer?. Journal of Biomedicine and Biotechnology 2010, pages 1-16.
Crossref
Crossref
Norasate Samarnthai, Kevin Hall & I-Tien Yeh. (2010) Molecular Profiling of Endometrial Malignancies. Obstetrics and Gynecology International 2010, pages 1-16.
Crossref
Crossref
Heather Wahl, Sayeema Daudi, Malti Kshirsagar, Kent Griffith, Lijun Tan, Jennifer Rhode & J. Rebecca Liu. (2010) Expression of metabolically targeted biomarkers in endometrial carcinoma. Gynecologic Oncology 116:1, pages 21-27.
Crossref
Crossref
Robert T. Abraham, James J. Gibbons & Edmund I. Graziani. 2010.
329
366
.
Wei Chen. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
719
748
.
Christina M. Annunziata & Herbert L. Kotz. (2009) Uterine papillary serous carcinoma. Cancer 115:16, pages 3594-3596.
Crossref
Crossref
Heidi A Lane & Madlaina Breuleux. (2009) Optimal targeting of the mTORC1 kinase in human cancer. Current Opinion in Cell Biology 21:2, pages 219-229.
Crossref
Crossref
Fanny Chan, Erika E. Samlowski & Wolfram E. Samlowski. (2009) Temsirolimus: A Review of its Use in the Treatment of Advanced Renal Cell Carcinoma. Clinical Medicine. Therapeutics 1, pages CMT.S2349.
Crossref
Crossref